VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 100 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,895,000 | +275.5% | 110,806 | +129.2% | 0.79% | +663.1% |
| Q4 2016 | $771,000 | -34.6% | 48,354 | -31.8% | 0.10% | -34.8% |
| Q3 2016 | $1,179,000 | +10.5% | 70,858 | +7.5% | 0.16% | -21.8% |
| Q2 2014 | $1,067,000 | -69.7% | 65,936 | -79.5% | 0.20% | -71.3% |
| Q3 2013 | $3,527,000 | +64.7% | 321,548 | +21.3% | 0.70% | +51.2% |
| Q2 2013 | $2,141,000 | – | 265,012 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,715,000 | $19,345,000 | 7.65% |
| Avoro Capital Advisors LLC | 2,124,593 | $23,965,000 | 6.23% |
| Asymmetry Capital Management, L.P. | 118,707 | $1,339,000 | 2.98% |
| ARMISTICE CAPITAL, LLC | 760,000 | $8,573,000 | 2.93% |
| Consonance Capital Management LP | 1,436,796 | $16,207,000 | 2.28% |
| Palo Alto Investors LP | 3,997,108 | $45,087,000 | 2.17% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,784,157 | $53,965,000 | 2.09% |
| PURA VIDA INVESTMENTS, LLC | 247,500 | $2,792,000 | 1.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,943,267 | $21,920,000 | 1.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 513,390 | $5,791,000 | 0.74% |